TY - CHAP
T1 - Direct Oral Anticoagulants and the Patient-Reported Outcomes
T2 - Synthesis and Advances
AU - Afzal, Saima
AU - Hasan, Syed Shahzad
AU - Babar, Zaheer-Ud-Din
PY - 2019/6/20
Y1 - 2019/6/20
N2 - Anticoagulation treatment with warfarin has been the gold standard of therapy for patients with atrial fibrillation to prevent stroke and for the treatment and prevention of venous thromboembolism. The development of direct oral anticoagulant agents over the past 10 years has created a shift in traditional management of these conditions. These new agents do not retain the pharmacokinetic and pharmacodynamic challenges associated with warfarin and do not require intensive blood monitoring and dose adjustment. Analyzing patient-reported outcomes incorporating patient satisfaction, adherence, compliance, and health-related quality of life gives prescribers and clinical practitioners an understanding of the patient perspectives of using DOACs. This article will focus on the patient-reported outcomes related to the DOAC treatment.
AB - Anticoagulation treatment with warfarin has been the gold standard of therapy for patients with atrial fibrillation to prevent stroke and for the treatment and prevention of venous thromboembolism. The development of direct oral anticoagulant agents over the past 10 years has created a shift in traditional management of these conditions. These new agents do not retain the pharmacokinetic and pharmacodynamic challenges associated with warfarin and do not require intensive blood monitoring and dose adjustment. Analyzing patient-reported outcomes incorporating patient satisfaction, adherence, compliance, and health-related quality of life gives prescribers and clinical practitioners an understanding of the patient perspectives of using DOACs. This article will focus on the patient-reported outcomes related to the DOAC treatment.
KW - Cost implications
KW - Direct oral anticoagulants
KW - Health-related quality of life
KW - Patient-Reported Outcomes
KW - Patient Satisfaction
UR - https://www.elsevier.com/books/encyclopedia-of-pharmacy-practice-and-clinical-pharmacy/babar/978-0-12-812735-3
UR - https://www.scopus.com/record/display.uri?eid=2-s2.0-85079081507&origin=inward&txGid=75f9279fe521028b3b527aa3b65d53f8
M3 - Entry for encyclopedia/dictionary
SN - 9780128127353
VL - 3A
SP - 898
EP - 908
BT - Encyclopedia of Pharmacy Practice and Clinical Pharmacy
A2 - Babar, Zaheer Ud-Din
PB - Elsevier
ER -
